Literature DB >> 29066182

Tetramethylpyrazine suppresses angiotensin II-induced soluble epoxide hydrolase expression in coronary endothelium via anti-ER stress mechanism.

Shiu-Kwong Mak1, Cheuk-Man Yu1, Wen-Tao Sun1, Guo-Wei He2, Xiao-Cheng Liu2, Qin Yang3.   

Abstract

Activation of soluble epoxide hydrolase (sEH) is associated with endothelial dysfunction in hypertension, though the underlying mechanisms are inadequately understood and the role of endoplasmic reticulum (ER) stress is yet to be studied in detail. Tetramethylpyrazine (TMP), a major bioactive ingredient of Chinese herb Chuanxiong, is well-known for its cardiovascular benefits. Nevertheless, whether TMP may protect vascular endothelium from ER stress and whether regulation of sEH is involved remain unknown. This study aimed at investigating the role of ER stress in angiotensin-II (Ang-II)-induced sEH dysregulation and elucidating the significance of ER stress regulation in the vasoprotective effect of TMP. Porcine primary coronary artery endothelial cells (PCECs) were used for western blot, ELISA, and reverse-transcription PCR analysis. Porcine coronary arteries were assessed in a myograph for endothelial dilator function. Ang-II induced expression of ER stress molecules in PCECs meanwhile enhanced sEH expression and decreased 11,12-EET. Exposure of PCECs to the chemical ER stress inducer tunicamycin also increased sEH expression. Inhibition of ER stress suppressed sEH upregulation, resulting in an increase of 11,12-EET. The impairment of endothelium-dependent vasorelaxation induced by Ang-II or tunicamycin was ameliorated by inhibitors of ER stress or sEH. TMP showed comparable inhibitory effect to ER stress inhibitors on the expression of ER stress molecules, the dysregulation of sEH/EET, and the impairment of endothelial dilator function. We demonstrated that ER stress mediates Ang-II-induced sEH upregulation in coronary endothelium. TMP has potent anti-ER stress capacity through which TMP normalizes sEH expression and confers protective effect against Ang-II on endothelial function of coronary arteries.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endoplasmic reticulum stress; Endothelial function; Soluble epoxide hydrolase; Tetramethylpyrazine; Vasorelaxing factors

Mesh:

Substances:

Year:  2017        PMID: 29066182     DOI: 10.1016/j.taap.2017.10.016

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

1.  Protective effects of tetramethylpyrazine on dysfunction of the locus coeruleus in rats exposed to single prolonged stress by anti-ER stress mechanism.

Authors:  Yun Hou; Meifeng Li; Yinchuan Jin; Feibo Xu; Shaohua Liang; Chen Xue; Kaili Wang; Wei Zhao
Journal:  Psychopharmacology (Berl)       Date:  2021-07-07       Impact factor: 4.530

Review 2.  Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.

Authors:  Shashank Shekhar; Mark W Cunningham; Mallikarjuna R Pabbidi; Shaoxun Wang; George W Booz; Fan Fan
Journal:  Eur J Pharmacol       Date:  2018-06-20       Impact factor: 4.432

Review 3.  Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure.

Authors:  Anzhu Wang; Wei Zhao; Kaituo Yan; Pingping Huang; Hongwei Zhang; Zhibo Zhang; Dawu Zhang; Xiaochang Ma
Journal:  Front Pharmacol       Date:  2022-02-24       Impact factor: 5.810

4.  Molecular mechanism of Chuanxiong Rhizoma in treating coronary artery diseases.

Authors:  Bang-Qiao Yin; Yu-Hong Guo; Yuan Liu; Yang-Yang Zhao; Shan-Mei Huang; Xia-Wei Wei; Heng-Sheng Wang; Ruo-Ya Liu; Ying Liu; Yao-Ping Tang
Journal:  Chin Herb Med       Date:  2021-03-17

5.  Targeting IRE1α-JNK-c-Jun/AP-1-sEH Signaling Pathway Improves Myocardial and Coronary Endothelial Function Following Global Myocardial Ischemia/Reperfusion.

Authors:  Hong-Mei Xue; Wen-Tao Sun; Huan-Xin Chen; Guo-Wei He; Qin Yang
Journal:  Int J Med Sci       Date:  2022-08-15       Impact factor: 3.642

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.